Shandong Jincheng Pharmaceutical Group Co., Ltd
public_traded
Shandong Jincheng Pharmaceutical Group Co., Ltd is publicly traded on SHZ under ticker 300233.SZ.
Shandong Jincheng Pharmaceutical Group Co., Ltd, together with its subsidiaries, researches and develops, produces, markets, and sells Cephalosporin intermediates in China and internationally. The company offers active pharmaceutical ingredients, biopharmaceuticals, medical intermediates, fine chemicals, finished dosages, and pharmaceutical products. It also provides animal nutrition and health care, as well as CMO and CDMO services. The company was founded in 2004 and is based in Zibo, China.